Metabolic Biomarker Testing Market

ID: MRFR/LS/4164-HCR

90 Pages

Rahul Gotadki

October 2025

Metabolic Biomarker Testing Market Research Report Information By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders), Application (Drug Discovery, Nutrigenomics, Toxicology Testing, Personalized Medicine), Technique, End User – Forecast To 2035

Metabolic Biomarker Testing Market Infographic

Single User

Multiple License

Enterprise User

Summary Table of Contents Segmentation Download PDF

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Customize Report

Metabolic Biomarker Testing Market Summary

The Global Metabolic Biomarker Testing Market is projected to grow from 3.68 USD Billion in 2024 to 9.72 USD Billion by 2035, reflecting a robust CAGR of 9.23% from 2025 to 2035.

Key Market Trends & Highlights

Metabolic Biomarker Testing Key Trends and Highlights

The market valuation is expected to reach 9.72 USD Billion by 2035, indicating substantial growth opportunities.
From a base year valuation of 3.68 USD Billion in 2024, the market is poised for significant expansion.
The compound annual growth rate (CAGR) of 7.93% from 2025 to 2035 suggests a strong upward trajectory in market demand.
Growing adoption of metabolic biomarker testing due to increasing prevalence of chronic diseases is a major market driver.

Metabolic Biomarker Testing Market

CAGR

9.23%

Market Size & Forecast

2024 Market Size	3.68 (USD Billion)
2035 Market Size	9.72 (USD Billion)
CAGR (2025-2035)	9.23%

Major Players

Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Thermo Fisher Scientific, Inc. (U.S.), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), Metabolon Inc. (U.S.)

Metabolic Biomarker Testing Market Trends

Metabolic biomarker testing is the process of identification and quantification of metabolites in a biological system. The steps involved in metabolic biomarker analysis are profiling, identification, quantification, and interpretation. Most healthcare professionals use diagnostic tests to clarify and support their clinical decision making.

The recent technological advancement is the key strategy implemented by major players to expand their reach in the global market and fortify their product portfolio. For instance, in November 2016, Metabolon, Inc. launched its novel product the Meta IMD test for diagnosing any hereditary metabolic issues. Moreover, in May 2016, Agilent Technologies Inc. global launch of the Agilent 5110 ICP-OES, an atomic spectroscopy.

Furthermore, the factors such as the rising demand for personalized medicine, increasing need for accurate diagnosis of diseases, increasing pharmaceutical and biotech R&D expenditure, huge investments by government & private players in the R&D are driving the market growth. Lack of awareness of metabolic biomarker and lack of skilled personnel to conduct these procedure are likely to restrain the market growth over the forecast period.

Metabolic Biomarker Testing Market Segmentation

The metabolic biomarker testing market is segmented on the basis of techniques, indications, application, and end user.

The increasing prevalence of metabolic disorders and the growing emphasis on personalized medicine appear to be driving advancements in metabolic biomarker testing, suggesting a transformative shift in healthcare diagnostics.

National Institutes of Health (NIH)

Metabolic Biomarker Testing Market Drivers

Rising Prevalence of Metabolic Disorders

The increasing incidence of metabolic disorders such as obesity, diabetes, and cardiovascular diseases is a primary driver for the Global Metabolic Biomarker Testing Market Industry. As of 2024, the market is valued at approximately 3.68 USD Billion, reflecting a growing demand for effective diagnostic tools. The World Health Organization indicates that the prevalence of diabetes has nearly doubled since 1980, highlighting the urgent need for metabolic biomarker testing. This surge in metabolic disorders necessitates innovative testing solutions, thereby propelling market growth and fostering advancements in biomarker technology.

Market Segment Insights

Metabolic Biomarker Testing Techniques Insights

On the basis of the techniques, the metabolic biomarker testing market is segmented into separation techniques, detection techniques. The separation techniques are categorized into liquid chromatography, gas chromatography, capillary chromatography. Moreover, the liquid chromatography segment is classified into high-performance liquid chromatography and ultra-performance liquid chromatography. Furthermore, detection techniques are divided into mass spectrometry, multivariate analysis, and spectroscopy. On the basis of detection techniques, spectroscopy is further classified into nuclear magnetic resonance spectroscopy, and Fourier transform infrared spectroscopy.

Metabolic Biomarker Testing Indication Insights

On the basis of the indication, the metabolic biomarker testing market is segmented into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and others.

Metabolic Biomarker Testing Application Insights

On the basis of the application, the metabolic biomarker testing market is segmented into drug discovery or drug assessment, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others.

Metabolic Biomarker Testing End user Insights

On the basis of the end user, the metabolic biomarker testing market is segmented into pharma & biotech companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories, and others.

The metabolic biomarker testing market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the metabolic biomarker testing market owing to the increasing applications of NGS procedures. The U.S. is the most prominent market in the region. Rising research activities undertaken by various biological and pharmaceutical industries in the region is anticipated to augment the metabolic biomarker testing market over the forecast period.

The European region is responsible for substantial market share in 2016. The European metabolic biomarker market is predicted to grow throughout the forecast period due to the presence of huge number of service provider for analytical equipment is expected to drive the metabolic biomarker market in this region.

The Asia Pacific region is likely to witness significant growth owing to the expansion of biotechnology and pharmaceutical industries in the region are some of the key factors driving the growth of the metabolic biomarker market.

Get more detailed insights about Metabolic Biomarker Testing Market Research Report- Forecast to 2032

Request Free Sample

Key Companies in the Metabolic Biomarker Testing Market market include

Future Outlook

Metabolic Biomarker Testing Market Future Outlook

The Metabolic Biomarker Testing Market is projected to grow at a 9.23% CAGR from 2025 to 2035, driven by advancements in technology, increasing prevalence of metabolic disorders, and rising demand for personalized medicine.

New opportunities lie in:

Develop innovative testing platforms integrating AI for enhanced accuracy and efficiency.
Expand partnerships with healthcare providers to improve accessibility and adoption of testing services.
Invest in research for novel biomarkers to address unmet clinical needs in metabolic health.

By 2035, the Metabolic Biomarker Testing Market is expected to achieve substantial growth, reflecting its critical role in healthcare.

Market Segmentation

Metabolic Biomarker Testing Market Key Players

Metabolon Inc. (U.S.)
LECO Corporation (U.S.
Human Metabolome Technologies Inc. (Japan)
Thermo Fisher Scientific, Inc. (U.S.)
Biocrates Life Sciences AG (Austria)
Shimadzu Corporation (Japan)
Waters Corporation (U.S.)
Danaher Corporation (U.S.)
Bruker Corporation (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Agilent Technologies , Inc. (U.S.)

Report Scope

Report Attribute/Metric	Details
Market Size 2024	USD 3.68 billion
Market Size 2035	9.72 (Value (USD Billion))
Compound Annual Growth Rate (CAGR)	9.23% (2025 - 2035)
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2018 & 2021
Market Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered	Indication, Application, End-User, and Region
Geographies Covered	North America, Europe, Asia Pacific, and Rest of the World
Countries Covered	The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled	Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Shimadzu Corporation (Japan), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S., Metabolon Inc. (U.S.)
Key Market Opportunities	Increasing demand for personalized medicines
Key Market Dynamics	Increasing government research funding and initiatives, escalated R&D activities
Market Size 2025	4.02 (Value (USD Billion))

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is Metabolic Biomarker Testing?

Metabolic Biomarker Testing is the process of identification and quantification of metabolites in a biological system.

What is the CAGR of the Metabolic Biomarker Testing?

The market is expected to exhibit a solid 9.23% CAGR over the forecast period from 2024 to 2032.

What is the major driver for the Metabolic Biomarker Testing?

The growing demand for personalized medication is a major driver for the Metabolic Biomarker Testing Market.

Which is the leading regional Metabolic Biomarker Testing?

The Americas dominate the global market due to the strong position of the healthcare sector in the region.

What are the leading Metabolic Biomarker Testing players?

Leading players in the Metabolic Biomarker Testing include Agilent, Bio-Rad Laboratories, and Bruker Corporation, among others.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027